The largest database of trusted experimental protocols

Slfn5 targeting rna oligonucleotides

Manufactured by Santa Cruz Biotechnology

SLFN5 targeting RNA oligonucleotides are synthetic, single-stranded RNA molecules designed to specifically target and bind to the SLFN5 gene transcript. The primary function of these oligonucleotides is to modulate the expression of the SLFN5 gene, which is involved in various cellular processes. These products are intended for research use only and do not have any implied or suggested therapeutic applications.

Automatically generated - may contain errors

2 protocols using slfn5 targeting rna oligonucleotides

1

Interferon Signaling Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human IFNα was obtained from Hoffmann-La Roche (USA). Recombinant human IFNβ was obtained from Biogen Idec (USA). Adult human normal brain lysate (ab30078) was obtained from Abcam (USA). The antibodies against STAT1, STAT3, STAT5 and Myc-Tag, were obtained from Cell Signaling Technology (USA). SLFN5, SLFN11 and SLFN12L antibodies were obtained from Sigma Aldrich (USA). GAPDH antibody was obtained from Millipore (USA). For RNAi mediated gene silencing, cells were transfected with double stranded control non-targeting or SLFN5 targeting RNA oligonucleotides (Santa Cruz Biotechnology, Santa Cruz, CA.). For transfection, Amaxa™ nucleofector kits from Lonza were used according to the manufacturer's instructions.
+ Open protocol
+ Expand
2

Interferon Signaling Pathway Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human IFNα was obtained from Hoffmann-La Roche (USA). Recombinant human IFNβ was obtained from Biogen Idec (USA). Adult human normal brain lysate (ab30078) was obtained from Abcam (USA). The antibodies against STAT1, STAT3, STAT5 and Myc-Tag, were obtained from Cell Signaling Technology (USA). SLFN5, SLFN11 and SLFN12L antibodies were obtained from Sigma Aldrich (USA). GAPDH antibody was obtained from Millipore (USA). For RNAi mediated gene silencing, cells were transfected with double stranded control non-targeting or SLFN5 targeting RNA oligonucleotides (Santa Cruz Biotechnology, Santa Cruz, CA.). For transfection, Amaxa™ nucleofector kits from Lonza were used according to the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!